The Board of Directors of Silva Pharmaceuticals Limited has recommended 3% cash dividend for shareholders excluding the Sponsors/Directors (except 1.5% for ICB) for the year ended June 30, 2022. The total amount of cash dividend payable to the general shareholders including ICB is BDT 24,189,812.00 only for 94,983,000 shares.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.2 BDT | 0.00% | +0.62% | -25.00% |
1st Jan change | Capi. | |
---|---|---|
-25.00% | 18.83M | |
+52.93% | 803B | |
+40.98% | 629B | |
-7.08% | 351B | |
+17.40% | 324B | |
+10.58% | 303B | |
+16.42% | 244B | |
+2.17% | 226B | |
+10.66% | 215B | |
+6.24% | 164B |
- Stock Market
- Equities
- SILVAPHL Stock
- News Silva Pharmaceuticals Limited
- Silva Pharmaceuticals Limited Recommends Cash Dividend for the Year Ended June 30, 2022